LABRHA EUROPEAN BOARD ON VISCOSUPPLEMENTATION
4 presentations for LABRHA at the 3rd Edition of the ISIAT Congress in Budapest last 1-3 October 2015

4 presentations for LABRHA at the 3rd Edition of the ISIAT Congress in Budapest last 1-3 October 2015

LABRHA participated in the 3rd International Symposium on Intra-Articular Treatment (ISIAT) Congress which took place in Budapest last 1-3 October 2015. The following 4 oral communications were presented for the company by Dr. Thierry Conrozier: Safety and efficacy of intra articular injections of a combination of hyaluronic acid and mannitol (HANOX-M) in patients with symptomatic...
LABRHA organized the 2nd Edition of the European Board on Viscosupplementation last september 2015

LABRHA organized the 2nd Edition of the European Board on Viscosupplementation last september 2015

After the success of the 1st Edition last 22-23 May 2014, LABRHA has decided to continue the adventure and launch the 2nd Edition of the European Board on Viscosupplementation. This 2nd Edition took place last 17-18 September 2015 in Lyon, France. The main objective of the LABRHA European Board on Viscosupplementation was, when LABRHA created...
1st publication for the European Board on Viscosupplementation created by LABRHA

1st publication for the European Board on Viscosupplementation created by LABRHA

Consensus statement on viscosupplementation with hyaluronic acid for the management of OA. Y. Henrotin; R. Raman; P. Richette; H. Bard, J. Jerosch; T. Conrozier; X. Chevalier; A. Migliore. Semin Arthritis Rheum. 2015 Apr 30. doi: 10.1016/j.semarthrit.2015.04.011 LABRHA who organized last 22-23 May 2014 in Lyon, France, the 1st Edition of the European Board on Viscosupplementation...
Labrha European Board on Viscosupplementation - 1st Edition -

Labrha European Board on Viscosupplementation – 1st Edition –

1st LABRHA EUROPEAN BOARD ON VISCOSUPPLEMENTATION LYON – MAY 22-23, 2014 OBJECTIVE: Organise a meeting and invite experts from several countries of Europe to debate on the viscosupplementation use in both knee and other joints affected by osteoarthritis (OA), share experiences and propose a consensual approach as well as recommendations to physicians to avoid risks of...